Aura Biosciences, Inc. Profile Avatar - Palmy Investing

Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It deve…

Biotechnology
US, Cambridge [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Aura Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Likelihood Legend A++ is best, F- worst
  • A++
  • A+
  • A

  • Very Unlikely
  • B+
  • B

  • Unlikely
  • C+
  • C
  • D+
  • D
  • D-

  • Avg.
  • E+
  • E-

  • Unlikely
  • F+
  • F
  • F-

  • Very Unlikely
Indicator

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

Rating
End of AURA's Analysis
CIK: 1501796 CUSIP: 05153U107 ISIN: US05153U1079 LEI: - UEI: -
Secondary Listings
AURA has no secondary listings inside our databases.